Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Immunocompromised children have a higher risk of developing infections and associated higher rates of mortality and morbidity. Although this group could benefit the most from vaccine administration, specific considerations regarding immunisations are required. This review is a summary of the vaccines that are relevant to the immunocompromised host, covering both live and non-live vaccines. The burden of disease, safety, immunogenicity/effectiveness and specific recommendations for each vaccine are described as well as specific guidelines from different organisations.

Original publication




Journal article


J Infect

Publication Date



72 Suppl


S13 - S22


Children, Immunocompromised, Immunogenicity, Recommendations, Safety, Vaccines, Child, Humans, Immunization, Immunocompromised Host, Immunogenicity, Vaccine, Infant, Practice Guidelines as Topic, Vaccines, Vaccines, Inactivated, Vaccines, Live, Unattenuated